PA
EDIT icon

Profund Advisors’s Editas Medicine EDIT Stock Holding History

Profund Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,808
Closed -$186K – 1139
2024
Q2 		$186K Sell
39,808
-84,033
-68% -$474K 0.01% 999
2024
Q1 		$919K Buy
123,841
+65,674
+113% +$546K 0.04% 378
2023
Q4 		$589K Sell
58,167
-24,940
-30% -$219K 0.03% 467
2023
Q3 		$648K Sell
83,107
-20,396
-20% -$175K 0.04% 391
2023
Q2 		$852K Sell
103,503
-22,239
-18% -$194K 0.05% 352
2023
Q1 		$912K Buy
+125,742
New +$1.12M 0.06% 323

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Profund Advisors's EDIT Position: Q3 2024 in Review

Profund Advisors sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 39,808 shares — an estimated $186K sold.

Profund Advisors first reported a position in EDIT in Q1 2023 and held it in 6 quarters. The position peaked at $919K in Q1 2024. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Profund Advisors reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Profund Advisors sold 39,808 Editas Medicine shares in Q3 2024, an estimated $186K.
  • Profund Advisors first reported a position in Editas Medicine in Q1 2023 and held it in 6 quarters.
  • Profund Advisors's Editas Medicine position peaked at $919K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Profund Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.